“tony-coles” Archives

in
Entry Author Date Location
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another 09/09/19 Boston
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Stifling Immigration Is “Retrograde”: Highlights From “What’s Hot” 05/17/17 Boston
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
One Year Post-Launch, Yumanity Lands $45M For Yeasty Discovery 02/10/16 Boston
Amid Neuroscience Renaissance, BlackThorn Quietly Builds a Business 12/23/15 San Francisco
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
With Fresh Eyes, A Return To Biotech’s City Within A City 06/24/15 Boston
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
From Iceland to White House, Precision Medicine’s Promises & Hurdles 03/31/15 National
What’s Hot in Boston Biotech? Here’s the Agenda 03/26/15 Boston
Seragon CEO Rich Heyman Is Going on Hiatus 02/20/15 San Diego
Find Out “What’s Hot in Boston Biotech” on April 8 02/05/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
NPS Pharma’s Long Road Ends With a $5.2B Shire Buyout 01/11/15 New York
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More 08/14/14 San Francisco
Una Ryan to Spearhead New Bay Area BioEconomy Initiative 11/11/13 San Francisco
Amgen Agrees to Buy Onyx for $125 Per Share, or $10.4B 08/25/13 San Francisco
Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks 07/15/13 National
Boston’s Got Big Mo in Biotech, But SF is Pushing Back 01/21/13 National
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Join Risa Stack, Tony Coles & More for ‘Reinventing Biotech’ 08/09/12 San Francisco
Page 1 of 2 next page »